The Current Ratio as of December 2025 (TTM) for Raphael Pharmaceutical Inc. (RAPH) is 0.03

According to Raphael Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.03. This represents a change of -57.06% compared to the average of 0.06 of the last 4 quarters.

Raphael Pharmaceutical Inc. (RAPH) Historical Current Ratio (quarterly & annually)

How has RAPH Current Ratio performed in the past?

The mean historical Current Ratio of Raphael Pharmaceutical Inc. over the last ten years is 1.18. The current 0.03 Current Ratio has changed 120.05% with respect to the historical average. Over the past ten years (40 quarters), RAPH's Current Ratio was at its highest in in the June 2024 quarter at 0.30. The Current Ratio was at its lowest in in the June 2025 quarter at 0.03.

Raphael Pharmaceutical Inc. (RAPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Raphael Pharmaceutical Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Raphael Pharmaceutical Inc. (RAPH) Average Current Ratio

How has RAPH Current Ratio performed in the past?

The current Current Ratio of Raphael Pharmaceutical Inc. (RAPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Raphael Pharmaceutical Inc. (RAPH) Current Ratio vs. Peers

How is RAPH’s Current Ratio compared to its peers?

Raphael Pharmaceutical Inc.’s Current Ratio is less than Isracann Biosciences Inc. (0.38), less than Voyageur Pharmaceuticals Ltd. (0.33), less than Avicanna Inc. (0.88), less than Global Pharmatech, Inc. (0.48), less than MediPharm Labs Corp. (3.11), less than INDVR Brands Inc. (0.35), less than Molecule Holdings Inc. (0.17), less than Choom Holdings Inc. (0.18), less than Elbit Imaging Ltd. (57.18), greater than Mydecine Innovations Group Inc. (0.00),

Build a custom stock screener for Raphael Pharmaceutical Inc. (RAPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Raphael Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Raphael Pharmaceutical Inc. (RAPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Raphael Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.